Citation Impact

Citing Papers

Selective targeting of engineered T cells using orthogonal IL-2 cytokine-receptor complexes
2018 StandoutScienceNobel
Complement and microglia mediate early synapse loss in Alzheimer mouse models
2016 StandoutScience
Tumor-reactive CD4+ T cells develop cytotoxic activity and eradicate large established melanoma after transfer into lymphopenic hosts
2010 StandoutNobel
Endosomal TLR signaling is required for anti-nucleic acid and rheumatoid factor autoantibodies in lupus
2009 StandoutNobel
Mannose-binding lectin enhances Toll-like receptors 2 and 6 signaling from the phagosome
2008
Species-Specific Recognition of Single-Stranded RNA via Toll-like Receptor 7 and 8
2004 StandoutScience
Blockade of CTLA-4 on both effector and regulatory T cell compartments contributes to the antitumor activity of anti–CTLA-4 antibodies
2009 StandoutNobel
Fc-dependent depletion of tumor-infiltrating regulatory T cells co-defines the efficacy of anti–CTLA-4 therapy against melanoma
2013 StandoutNobel
Innate and Adaptive Immunity Cooperate Flexibly to Maintain Host-Microbiota Mutualism
2009 StandoutScienceNobel
Cancer Regression in Patients After Transfer of Genetically Engineered Lymphocytes
2006 StandoutScience
Beta-glucan functions as an adjuvant for monoclonal antibody immunotherapy by recruiting tumoricidal granulocytes as killer cells.
2003
Human CTLA4 knock-in mice unravel the quantitative link between tumor immunity and autoimmunity induced by anti–CTLA-4 antibodies
2005
rC5a Directs the In Vitro Migration of Human Memory and Naive Tonsillar B Lymphocytes: Implications for B Cell Trafficking in Secondary Lymphoid Tissues
1999
Schizophrenia risk from complex variation of complement component 4
2016 StandoutNature
Fcγ receptor-dependent effector mechanisms regulate CD19 and CD20 antibody immunotherapies for B lymphocyte malignancies and autoimmunity
2006
T Cell-Independent Somatic Hypermutation in Murine B Cells with an Immature Phenotype
2004
Nucleotides released by apoptotic cells act as a find-me signal to promote phagocytic clearance
2009 StandoutNature
The Role of Complement in Inflammatory Diseases From Behind the Scenes into the Spotlight
2007
Complement and its role in innate and adaptive immune responses
2009 Standout
A view on drug resistance in cancer
2019 StandoutNature
Complement receptors CD21 and CD35 in humoral immunity
2007
mRNA Is an Endogenous Ligand for Toll-like Receptor 3
2004 StandoutNobel
CD72-Deficient Mice Reveal Nonredundant Roles of CD72 in B Cell Development and Activation
1999
Complement Component 3 Adapts the Cerebrospinal Fluid for Leptomeningeal Metastasis
2017
CD22 blockade restores homeostatic microglial phagocytosis in ageing brains
2019 StandoutNatureNobel
THE ALLOGENEIC T AND B CELL RESPONSE IS STRONGLY DEPENDENT ON COMPLEMENT COMPONENTS C3 AND C41
2001
Complement Receptors CD21/35 Link Innate and Protective Immunity during Streptococcus pneumoniae Infection by Regulating IgG3 Antibody Responses
2002
Complement-Mediated Ischemia-Reperfusion Injury
2009
Alymphoplasia is caused by a point mutation in the mouse gene encoding Nf-κb-inducing kinase
1999 StandoutNobel
Complement component C3 promotes T-cell priming and lung migration to control acute influenza virus infection
2002
A role of macrophage complement receptor CRIg in immune clearance and inflammation
2008
Recognition of microorganisms and activation of the immune response
2007 StandoutNature
Complement and the immune response
1997
Complexity of complement activation in sepsis
2008
Protective effects of C5a blockade in sepsis
1999
Complement: a key system for immune surveillance and homeostasis
2010 Standout
Alzheimer Disease: An Update on Pathobiology and Treatment Strategies
2019 Standout
The alternative complement pathway revisited
2008
Evolving concepts of rheumatoid arthritis
2003 StandoutNature
Missing Pieces in the NF-κB Puzzle
2002 Standout
Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells
2006 StandoutNature
Senescence and tumour clearance is triggered by p53 restoration in murine liver carcinomas
2007 StandoutNature
Phosphorylation-Driven Assembly of the RIP1-RIP3 Complex Regulates Programmed Necrosis and Virus-Induced Inflammation
2009 Standout
Toll-Like Receptors and Activation of Autoreactive B Cells
2002
Synthetic Par polarity induces cytoskeleton asymmetry in unpolarized mammalian cells
2023 StandoutNobel
Arthritis Critically Dependent on Innate Immune System Players
2002
How dying cells alert the immune system to danger
2008
Complement Deficiency and Autoimmunitya
1997
OPGL is a key regulator of osteoclastogenesis, lymphocyte development and lymph-node organogenesis
1999 StandoutNature
Systemic Lupus Erythematosus
2011 Standout
The clearance of apoptotic cells by complement
2006
Autoimmunity, Complement Activation, Tissue Injury and Reciprocal Effects
2003
Aspiration Pneumonitis and Aspiration Pneumonia
2001 Standout
The Classical Complement Cascade Mediates CNS Synapse Elimination
2007 Standout
Complement amplification revisited
2005
Complement and humoral immunity
2008
Macrophage complement receptors and pathogen clearance
2007
Complement
2001 Standout
Origin and physiological roles of inflammation
2008 StandoutNature
Complement inhibitors: a resurgent concept in anti-inflammatory therapeutics
2000
The Pathophysiology and Treatment of Sepsis
2003 Standout
Role of aquaporins in alveolar fluid clearance in neonatal and adult lung, and in oedema formation following acute lung injury: studies in transgenic aquaporin null mice
2000
Cell-derived anaphylatoxins as key mediators of antibody-dependent type II autoimmunity in mice
2006
A Dominant Complement Fixation Pathway for Pneumococcal Polysaccharides Initiated by SIGN-R1 Interacting with C1q
2006 StandoutNobel
Autoreactivity by design: innate B and T lymphocytes
2001
Points of control in inflammation
2002 StandoutNature
Dendritic cells and the control of immunity
1998 StandoutNatureNobel
Chromatin–IgG complexes activate B cells by dual engagement of IgM and Toll-like receptors
2002 StandoutNature
The role of the anaphylatoxins in health and disease
2009
The spectrum of complement alternative pathway‐mediated diseases
2008
Distinct Roles in Lymphoid Organogenesis for Lymphotoxins α and β Revealed in Lymphotoxin β–Deficient Mice
1997
Inferences, questions and possibilities in Toll-like receptor signalling
2004 StandoutNatureNobel
The dark side of C5a in sepsis
2004
Modulation of the antitumor immune response by complement
2008
Membrane dynamics of dividing cells imaged by lattice light-sheet microscopy
2016 Nobel
IgMhighCD21high Lymphocytes Enriched in the Splenic Marginal Zone Generate Effector Cells More Rapidly Than the Bulk of Follicular B Cells
1999
Activation-induced cytidine deaminase (AID) promotes B cell lymphomagenesis in Emu-cmyc transgenic mice
2007 StandoutNobel
Central Role of Complement in Passive Protection by Human IgG1 and IgG2 Anti-pneumococcal Antibodies in Mice
2003
The C-type lectin SIGN-R1 mediates uptake of the capsular polysaccharide ofStreptococcus pneumoniaein the marginal zone of mouse spleen
2003 StandoutNobel
Impaired Antibody Response to Group B Streptococcal Type III Capsular Polysaccharide in C3- and Complement Receptor 2-Deficient Mice
2003
Dependence of Germinal Center B Cells on Expression of CD21/CD35 for Survival
1998 Science
THE ROLE OF COMPLEMENT AND COMPLEMENT RECEPTORS IN INDUCTION AND REGULATION OF IMMUNITY
1998
Interaction with Complement Receptor 1 (CD35) Leads to Amelioration of Sepsis‐Triggered Mortality but Aggravation of Arthritis During Staphylococcus aureus Infection
1999
A Macrophage Invasion Mechanism of Pathogenic Mycobacteria
1997 Science
The classical pathway is the dominant complement pathway required for innate immunity toStreptococcus pneumoniaeinfection in mice
2002
Critical Roles of Pten in B Cell Homeostasis and Immunoglobulin Class Switch Recombination
2003 StandoutNobel
Distinct Roles of Lymphotoxin α and the Type I Tumor Necrosis Factor (TNF) Receptor in the Establishment of Follicular Dendritic Cells from Non–Bone Marrow–derived Cells
1997
Role of CD47 as a Marker of Self on Red Blood Cells
2000 StandoutScience
The Role of Complement in the Development of Systemic Lupus Erythematosus
2004
Drug Discovery: A Historical Perspective
2000 StandoutScience
Decreased pulmonary vascular permeability in aquaporin-1-null humans
2002 StandoutNobel
How neuroinflammation contributes to neurodegeneration
2016 StandoutScience
Germinal Centers
2012
Complement C4 Inhibits Systemic Autoimmunity through a Mechanism Independent of Complement Receptors Cr1 and Cr2
2000
Dendritic cell maturation by innate lymphocytes
2005 StandoutNobel
The Peritoneal Cavity Provides a Protective Niche for B1 and Conventional B Lymphocytes during Anti-CD20 Immunotherapy in Mice
2005
Superantigen overcomes resistance of IL‐6‐deficient mice towards MOG‐induced EAE by a TNFR1 controlled pathway
2001
Abnormal B lymphocyte development and autoimmunity in hypoxia-inducible factor 1α-deficient chimeric mice
2002 StandoutNobel
The Innate Mononuclear Phagocyte Network Depletes B Lymphocytes through Fc Receptor–dependent Mechanisms during Anti-CD20 Antibody Immunotherapy
2004
PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine
2001 StandoutNobel
Generation of C5a in the absence of C3: a new complement activation pathway
2006
Decoding the Patterns of Self and Nonself by the Innate Immune System
2002 StandoutScience
Cyclic AMP plays a critical role in C3a-receptor–mediated regulation of dendritic cells in antigen uptake and T-cell stimulation
2008
The Inflammatory Response to Cell Death
2008
Tumor Regression and Autoimmunity after Reversal of a Functionally Tolerant State of Self-reactive CD8+ T Cells
2003
Novel Mechanism of Antibody-Independent Complement Neutralization of Herpes Simplex Virus Type 1
2000
Origins and Functions of B-1 Cells with Notes on the Role of CD5
2002
Structural basis for Zika envelope domain III recognition by a germline version of a recurrent neutralizing antibody
2020 StandoutNobel
Follicular Dendritic Cells Specifically Express the Long CR2/CD21 Isoform
1997
Cutting Edge Commentary: Origins of B-1 Cells
2001
Adjuvant-Enhanced Antibody Responses in the Absence of Toll-Like Receptor Signaling
2006 StandoutScienceNobel
FcγRIII and FcγRIV Are Indispensable for Acute Glomerular Inflammation Induced by Switch Variant Monoclonal Antibodies
2008
JNK1 controls mast cell degranulation and IL-1β production in inflammatory arthritis
2010 StandoutNobel
Nuclear Factor (NF)-κB2 (p100/p52) Is Required for Normal Splenic Microarchitecture and B Cell–mediated Immune Responses
1998

Works of Minghe Ma being referenced

Identification of a specific self-reactive IgM antibody that initiates intestinal ischemia/reperfusion injury
2004
Redundant and Alternative Roles for Activating Fc Receptors and Complement in an Antibody-Dependent Model of Autoimmune Vitiligo
2002
Disruption of the Cr2 Locus Results in a Reduction in B-1a Cells and in an Impaired B Cell Response to T-Dependent Antigen
1996
Increased susceptibility to endotoxin shock in complement C3- and C4-deficient mice is corrected by C1 inhibitor replacement.
1997
Regulation of the B cell response to T-dependent antigens by classical pathway complement.
1996
Reperfusion injury of ischemic skeletal muscle is mediated by natural antibody and complement.
1996
Complement activation in factor D-deficient mice
2001
Complement C4 Is Protective for Lupus Disease Independent of C3
2002
Studies of group B streptococcal infection in mice deficient in complement component C3 or C4 demonstrate an essential role for complement in both innate and acquired immunity.
1995
Humoral response to herpes simplex virus is complement-dependent
1999
Local Synthesis of C3 Within the Splenic Lymphoid Compartment Can Reconstitute the Impaired Immune Response in C3-Deficient Mice
1998
Experimental murine acid aspiration injury is mediated by neutrophils and the alternative complement pathway
1997
Identification and Characterization of a Novel Broad-Spectrum Virus Entry Inhibitor
2016
Rankless by CCL
2026